08.08.13
PAREXEL
4Q Revenues: $526.9 million (+15%)
4Q Earnings: $30.0 million (+69%)
FY Revenues: $2.0 billion (+23%)
FY Earnings: $96.0 million (+52%)
Comments: Clinical Research Services (CRS) revenue was $343.4 million in the quarter (+18%) and $1.3 billion for the year (+26%). PAREXEL Consulting and Medical Communications Services (PCMS) revenue was $54.3 million in the quarter (+9%) and $202.5 million for the year (+21%). Perceptive Informatics revenue was $65.4 million in the quarter (+29%) and $228.3 million for the year (+20%). Recent acquisitions contributed approximately $12.7 million to revenue in the quarter. Net book-to-bill ratio of 1.21 in the quarter, with net new business wins of $559.2 million and backlog exceeded $4.6 billion.
4Q Revenues: $526.9 million (+15%)
4Q Earnings: $30.0 million (+69%)
FY Revenues: $2.0 billion (+23%)
FY Earnings: $96.0 million (+52%)
Comments: Clinical Research Services (CRS) revenue was $343.4 million in the quarter (+18%) and $1.3 billion for the year (+26%). PAREXEL Consulting and Medical Communications Services (PCMS) revenue was $54.3 million in the quarter (+9%) and $202.5 million for the year (+21%). Perceptive Informatics revenue was $65.4 million in the quarter (+29%) and $228.3 million for the year (+20%). Recent acquisitions contributed approximately $12.7 million to revenue in the quarter. Net book-to-bill ratio of 1.21 in the quarter, with net new business wins of $559.2 million and backlog exceeded $4.6 billion.